Liangyihui.net, an innovative digital medical platform in the oncology field, announced the completion of a Series C financing of over 100 million yuan. Qiming Venture Partners led this round of financing with participation from DT Capital. Existing investors Redhill Capital, Wang Jiaquan Family Office, Yuanju Capital, and Jiangsu Juhe Capital Management also participated. HaoYue Capital acted as the exclusive financial advisor. Founded in 2015, Liangyihui.net has gathered the largest number of online oncology doctors and patients, with nearly 200,000 oncologists and about 300,000 oncology patients. After 6 years of content-led…
This round of financing was led by DT Capital and Golden China Fund, with participation from investment institutions including Sunshine Insurance Group, OrbiMed, China Merchants Securities Investment, Finnova Capital, Horus Capital, Unifortune, and Series A investors GF Venture Capital, Yantai Finance Investment Group and others.